Abstract
In this chapter, we will examine published data regarding patient cohorts assembled for specific pharmacologic interventions addressed to specified medical complications of heavy alcohol consumption. The review will evaluate only peer-assessed publications that: (1) included full disclosure of their methodology; (2) identified the proportion of alcoholics among heterogeneous patient groups with a given clinical diagnosis (e. g., pancreatitis); (3) used standard diagnostic criteria; and (4) employed a control group whose clinical characteristics matched those of the study group. Whenever possible, our presentation will describe two categories of facts: (1) confirmations (i. e., similar findings obtained by at least two independent research groups) and (2) contradictions (i. e., unequivocally opposite findings in independent studies with similar methodology).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Achord JL (1987) A prospective randomized clinical trial of peripheral amino acid-glucose supplementation in acute alcoholic hepatitis. Am J Gastroenterol 82: 871–875
Akriviadis EA, Steindel H, Pinto PC, Fong TL, Kanel G, Reynolds TB and Gupta S (1990) Failure of colchicine to improve short-term survival in patients with alcoholic hepatitis. Gastroenterology 99:811–818
Andreani T, Poupon RE, Baikau BJ et al. (1990) Preventive therapy of first gastrointestinal bleeding in patients with cirrhosis: results of a controlled trial comparing propranolol, endoscopic sclerotherapy and placebo. Hepatology 12: 1413–1419
Anonymous (1982) (+)-Cyanindanol-3. Lancet 1:549
Anonymous (1987) Lactitol. Lancet 2:81–82
Anonymous (1988a) Diuretics or paracentesis for ascites? Lancet 2:775–776
Anonymous (1988b) Propylthiouracil and alcoholic liver disease. Lancet 1:450
Baxter AL, Jaspan JB, Haines NW, Hatfield GE, Krager PS, Schneider JF, University of Chicago Medical Housestaff (1981) A randomized clinical trial of insulin and glucagon infusion for treatment of alcoholic hepatitis: progress report in 50 patients. Gastroenterology 80:1410–1414
Bexter JN, Jenkins SA, Day DW (1985) Effects of somatostatin and a long-acting somatostatin analogue on the prevention and treatment of experimentally induced acute pancreatitis in the rat. Br J Surg 72:382–385
Bansky G, Meier PJ, Riederer E, Walser H, Ziegler WH, Schmid M (1989) Effects of the benzodiazepine receptor antagonist flumazenil in hepatic encephalopathy in humans. Gastroenterology 97:744–750
Baraldi M, Zeneroli ML, Ventura E et al. (1984) Supersensitivity of benzodiazepine receptors in hepatic encephalopathy due to fulminant hepatic failure in the rat: reversal by a benzodiazepine antagonist. Clin Sci 67:167–175
Basile AS, Hughes RD, Harrison PM, Murata Y, Pannell L, Jones EA, Williams R, Skolnick P (1991) Elevated brain concentrations of 1,4-benzodiazepines in fulminant hepatic failure. N Engl J Med 325:473–478
Berlin JA, Chalmers TC (1989) Meta-analysis of branched-chain amino acids in hepatic encephalopathy. Gastroenterology 97:1043–1045
Bird GLA, Williams R (1990) Treatment of advanced alcoholic liver disease. Alcohol Alcohol 25:197–206
Bird G, Lau JYN, Koskinas J, Wicks C, Williams R (1991) Insulin and glucagon infusion in acute alcoholic hepatitis: a prospective randomized controlled trial. Hepatology 14:1097–1101
Bonkovsky HL, Fiellen DA, Smith GS, Slaker DP, Simon D, Galambos JT (1991a) A randomized, controlled trial of treatment of alcoholic hepatitis with parenteral nutrition and oxandrolone. I. Short-term effects on liver function. Am J Gastroenterol 86:1200–1208
Bonkovsky HL, Singh RH, Jafri IH, Fiellin DA, Smith GS, Simon D, Cotsonis GA, Slaker DP (1991b) A randomized controlled trial of treatment of alcoholic hepatitis with parenteral nutrition and oxandrolone. II. Short-term effects on nitrogen metabolism, metabolic balance, and nutrition. Am J Gastroenterol 86:1209–1218
Boyer JL, Ransohoff DF (1988) Is colchicine effective therapy for cirrhosis? N Engl J Med 318:1751–1752
Boyer TD, Warnock DG (1983) Use of diuretics in the treatment of cirrhotic ascites. Gastroenterology 84:1051–1055
Burroughs AK, Hamilton G, Phillips A, Mezzanotte G, Mclntyre N, Hobbs KEF (1989) A comparison of sclerotherapy with staple transection of the esophagus for the emergency control of bleeding from esophageal varices. N Engl J Med 321:857–862
Cabre E, Gonzalez-Huix F, Abad-LaCruz A, Esteve M, Acero D, Fernandez-Bañares F, Xiol X, Gassull MA (1990) Effect of total enteral nutrition on the short-term outcome of severely malnourished cirrhotics. Gastroenterology 98: 715–720
Calvey H, Davis M, Williams R (1985) Controlled trial of nutritional supplementation, with and without branched chain amino acid enrichment, in treatment of acute alcoholic hepatitis. J Hepatol 1:141–151
Cameron JL, Mehigan D, Zuidema GD (1979) Evaluation of atropine in acute pancreatitis. Surg Gynecol Obstet 148:206–208
Cello JP, Grendell JH, Crass RA, Weber TE, Trunkey DD (1987) Endoscopic sclerotherapy versus portacaval shunt in patients with severe cirrhosis and acute variceal hemorrhage: long-term follow-up. N Engl J Med 316:11–15
Choi TK, Mok F, Zhan WH, Fan ST, Lai ECS, Wong J (1989) Somatostatin in the treatment of acute pancreatitis: a prospective randomized controlled trial. Gut 30:223–227
Colombo M, De Franchis R, Tommasini M, Sangiovanni A, Dioguardi N (1989) ß-Blockade prevents recurrent gastrointestinal bleeding in well-compensated patients with alcoholic cirrhosis: a multicenter randomized controlled trial. Hepatology 9:433–438
D’Amico D, Favia G, Biasiato R, Casaccia M, Falcone F, Fersini M, Marrano D, Napolitano F, Oliviero S, Rodolico A (1990) The use of somatostatin in acute pancreatitis: results of a multicenter trial. Hepatogastroenterology 37:92–98
De Franchis R, North Italian Endoscopic Club for the Study and Treatment of Esophageal Varices (1988) Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices. N Engl J Med 319:983–989
Diegelman RF, Peterkofsky B (1972) Inhibition of collagen secretion from bone and cultured fibroblasts by microtubular disruptive drugs. Proc Natl Acad Sei USA 69:892–896
Diehl AM, Boitnott JK, Herlong HF et al. (1985) Effect of parenteral amino acid supplementation in alcoholic hepatitis. Hepatology 5:57–63
Dindzans VJ, Gavaler JS, Tarter RE, Van Thiel DH (1989) Liver transplantation. Contemp Gastroenterol 2:9–16
Dinoso VP, Chey WY, Braverman SP, Rosen AR, Ottenberg D, Lorber SH (1972) Gastric secretion and gastric mucosal morphology in chronic alcoholics. Arch Intern Med 130:715–719
Dollinger HC, Raptis S, Pfeiffer EF (1976) Effects of somatostatin on exocrine and endocrine pancreatic function stimulated by intestinal hormones in man. Horm Metab Res 8:74–78
Egberts EH, Schomerus H, Hamster W, Jürgens P (1985) Branched chain amino acids in the treatment of latent portosystemic encephalopathy. Gastroenterology 88:887–895
Epstein M (1989) Treatment of refractory ascites. N Engl J Med 321:1675–1677
Eriksson LS, Conn HO (1989) Branched-chain amino acids in the management of hepatic encephalopathy: an analysis of variants. Hepatology 10:228–246
Erlich HP, Bornstein P (1972) Microtubules in transcellular movement of procollagen. Nature 238:257–260
Erlich HP, Ross R, Bornstein P (1974) Effects of antimicrotubular agents on the secretion of collagen. J Cell Biol 62:390–405
Ferenci P, Grimm G, Meryn S, Gangl A (1989) Successful long-term treatment of portal-systemic encephalopathy by the benzodiazepine antagonist flumazenil. Gastroenterology 96:240–243
Field BW, Heppner GW, Shabot MM, Schwartz AA, State D, Worthen N, Wilson R (1979) Nasogastric suction in alcohol pancreatitis. Dig Dis Sci 24:339–344
Frakes JT (1980) Physiologic considerations in the medical management of ascites. Arch Intern Med 140:620–623
Gammal SH, Jones EA (1989) Hepatic encephalopathy. Med Clin North Am 73: 793–813
Garden OJ, Mills PR, Birnie GG, Murray GD, Carter DC (1990) Propranolol in the prevention of recurrent variceal hemorrhage in cirrhotic patients. Gastroenterology 98:185–190
Ginès P, Arroyo V, Quintero E, Planas R, Bory F, Cabrera J, Rimóla A, Viver J, Camps J, Jiménez W, Mastai R, Gaya J, Rodés J (1987) Comparison of paracentesis and diuretics in the treatment of cirrhotics with tense ascites. Gastroenterology 93:234–241
Ginès P, Arroyo V, Vargas V, Planas R, Casafont F, Panés J, Hoyos M, Viladomiu L, Rimóla A, Morillas R, Salmerón JM, Ginès A, Esteban R, Rodés J (1991) Paracentesis with intravenous infusion of albumin as compared with perito-neovenous shunting in cirrhosis with refractory ascites. N Engl J Med 325:829–835
Goff JS, Feinberg LE, Brugge WR (1982) A randomized trial comparing Cimetidine to nasogastric suction in acute pancreatitis. Dig Dis Sci 27:1085–1088
Gottfried EB, Korsten MA, Lieber CS (1978) Alcohol-induced gastric and duodenal lesions in man. Am J Gastroenterol 70:587–592
Grimm G, Ferenci P, Katzenschlager R, Madl C, Schneeweiss B, Laggner AN, Lenz K, Gangl A (1988) Improvement of hepatic encephalopathy treated with flumazenil. Lancet 2:1392–1394
Hadas N, Wapnick S, Groskero SJ (1978) Cimetidine in pancreatitis (letter). N Engl J Med 299:487
Hallé P, Paré P, Kaptein E, Kanel G, Redeker AG, Reynolds TB (1982) Double-blind, controlled trial of propylthiouracil in patients with severe acute alcoholic hepatitis. Gastroenterology 82:925–931
Hammer R, Berrie CP, Birdsall NJM, Burgen ASV, Hulme EC (1980) Pirenzepine distinguishes between different subclasses of muscarinic receptors. Nature 383: 90–92
Harris ED, Krane SM (1971) Effects of colchicine on collagenase in cultures of rheumatoid synovium. Arthritis Rheum 14:669–684
Hayes PC, Davis JM, Lewis JA, Bouchier IAD (1990) Meta-analysis of value of propranolol in prevention of variceal haemorrhage. Lancet 336:153–156
Henderson JM, Kutner MH, Millikan WJ, Galambos JT, Riepe SP, Brooks WS, Bryan FC, Warren WD (1990) Endoscopic variceal sclerosis compared with distal splenorenal shunt to prevent recurrent variceal bleeding in cirrhosis. Ann Intern Med 112:262–269
Horst D, Grace ND, Conn HO, Schiff E, Schenker S, Viteri A, Law D, Atterbury CE (1984) Comparison of dietary protein with an oral, branched chain-enriched amino acid supplement in chronic portal-systemic encephalopathy: a randomized controlled trial. Hepatology 4:279–287
Imperiale TF, McCullough AJ (1990) Do corticosteroids reduce mortality from alcoholic hepatitis? Ann Intern Med 113:299–307
Israel Y, Videla L, Bernstein J (1975) Liver hypermetabolic state after chronic ethanol consumption: hormonal interrelationships and pathogenic implications. Fed Proc 34:2052–2059
Joffe SN, Lee FD (1978) Acute pancreatitis after Cimetidine administration in experimental duodenal ulcer (letter). Lancet 1:383
Kaplowitz N (1982) Propylthiouracil treatment for alcoholic hepatitis: should it and does it work? Gastroenterology 82:1468–1472
Kearns PJ, Young H, Garcia G, Blaschke T, O’Hanlon G, Rinki M, Sucher K, Gregory P (1992) Accelerated improvement of alcoholic liver disease with enteral nutrition. Gastroenterology 102:200–205
Kellerman PS, Linas SL (1990) Large-volume paracentesis in treatment of ascites. Ann Intern Med 112:889–891
Kershenobich D, Uribe M, Suárez GI, Mata JM, Pérez-Tamayo R, Rojkind M (1979) Treatment of cirrhosis with colchicine. Gastroenterology 77:532–536
Kershenobich D, Vargas F, Garcia-Tsao G, Perez-Tamayo R, Gent M, Rojkind M (1988) Colchicine in the treatment of cirrhosis of the liver. N Engl J Med 318:1709–1713
Lanza FL, Nelson RS, Rack MF (1984) A controlled endoscopic study comparing the toxic effects of sulindac, naproxen, aspirin, and placebo on the gastric mucosa of healthy volunteers. J Clin Pharmacol 24:89–95
Levant JA, Secrist DM, Resin H, Sturdevant RAL, Guth PH (1974) Nasogastric suction in the treatment of alcoholic pancreatitis. A controlled study. JAMA 229:51–52
Lieber CS (1990) Interaction of alcohol with other drugs and nutrients. Drugs 40 [Suppl 3]:23—44
Lucey MR, Merion RM, Henley KS, Campbell DA, Turcotte JG, Nostrant TT, Blow FC, Beresford TP (1992) Selection for and outcome of liver transplantation in alcoholic liver disease. Gastroenterology 102:1736–1741
Maddrey WC (1979) Propylthiouracil treatment of alcoholic hepatitis. Gastroenterology 76:218–219
Maddrey WC (1988) Alcoholic hepatitis: clinicopathologic features and therapy. Semin Liver Dis 8:91–102
Marshall BJ (1983) Unidentified curved bacilli in the stomach of patients with active chronic gastritis. Lancet 2:1273–1275
Mendenhall CL, Tosch T, Weesner RE, Garcia-Pont P, Goldberg SJ, Kiernan T, Seeff LB, Sorrell M, Tamburro C, Zetterman R, Chedid A, Chen T, Rabin L (1986) VA cooperative study on alcoholic hepatitis II: prognostic significance of protein-calorie malnutrition. Am J Clin Nutr 43:213–218
Meshkinpour H, Molinari MD, Gardner L, Berk JE, Hoehler FK (1979) Cimetidine in the treatment of acute alcoholic pancreatitis. A randomized, double-blind study. Gastroenterology 77:687–690
Mezey E, Caballería J, Mitchell MC, Parés A, Herlong HF, Rodés J (1991) Effect of parenteral amino acid supplementation on short-term and long-term outcomes in severe alcoholic hepatitis: a randomized controlled trial. Hepatology 14: 1090–1096
Moreno-Otero R, Rodriguez S, Carbo J, Garcia-Buey L, Pajares JM (1989) Double-blind trial of pirenzepine in acute pancreatitis. Digestion 42:51–56
Mullen KD, Martin JV, Mendelson WB, Bassett ML, Jones EA (1988) Could an endogenous benzodiazepine ligand contribute to hepatic encephalopathy? Lancet 1:457–459
Mullen KD, Szauter KM, Kaminsky-Russ K (1990) “Endogenous” benzodiazepine activity in body fluids of patients with hepatic encephalopathy. Lancet 336: 81–83
Naeijie R, Salingret E, Clumeck N, DeTroyer A, Devis G (1978) Is nasogastric suction necessary in acute pancreatitis? Br Med J 2:659–660
Nasrallah SM, Galambos JT (1980) Aminoacid therapy of alcoholic hepatitis. Lancet 2:1276–1277
Naylor CD, O’Rourke K, Detsky AS, Baker JP (1989) Parenteral nutrition with branched-chain amino acids in hepatic encephalopathy. Gastroenterology 97: 1033–1042
O’Connor KW, Lehman G, Yune H, Brunelle R, Christiansen P, Hast J, Compton M, McHenry R, Klatte E, Cockerill E, Holden R, Becker G, Kopecky K, Hawes R, Pound D, Rex D, Lui A, Snodgrass P, Weddle R, Crabb D, Lumeng L (1989) Comparison of three nonsurgical treatments for bleeding esophageal varices. Gastroenterology 96:899–906
Orrego H, Kalant H, Israel Y, Blake J, Medline A, Rankin JG, Armstrong A, Kapur B (1979) Effect of short-term therapy with propylthiouracil in patients with alcoholic liver disease. Gastroenterology 76:105–115
Orrego H, Blake JE, Blendis LM, Compton KV, Israel Y (1987) Long-term treatment of alcoholic liver disease with propylthiouracil. N Engl J Med 317: 1421–1427
Pagliaro L, Burroughs AK, Sorensen TIA, Lebrec D, Morabito A, Amico GD, Tine F (1990) Beta-blockers for preventing variceal bleeding. Lancet 336:1001–1002
Pagliaro L, D’Amico G, Sörensen TIA, Lebrec D, Burroughs AK, Morabito A, Tiné F, Politi F, Traina M (1992) Prevention of first bleeding in cirrhosis. Ann Intern Med 117:59–70
Pascal JP, Cales P, Multicenter Study Group (1987) Propranolol in the prevention of first upper gastrointestinal tract hemorrhage in patients with cirrhosis of the liver and esophageal varices. N Engl J Med 317:856–861
Pitchumoni CS, Glass GBJ (1976) Patterns of gastritis in alcoholics. Biol Gastroenterol 9:11–16
Planas R, Boix J, Broggi M, Cabré E, Gomes-Vieira MC, Morillas R, Armengol M, de León R, Humbert P, Salvá JA, Gassuli MA (1991) Portacaval shunt versus endoscopic sclerotherapy in the elective treatment of variceal hemorrhage. Gastroenterology 100:1078–1086
Polio J, Groszmann RJ (1989) Bleeding esophageal varices. Pract Gastroenterol 13:41–50, 72
Poynard T, Calés P, Pasta L, Ideo G, Pascal JP, Pagliaro L, Lebrec D, Franco-Italian Multicenter Study Group (1991) Beta-adrenergic-antagonist drugs in the prevention of gastrointestinal bleeding in patients with cirrhosis and esophageal varices. N Engl J Med 324:1532–1538
Quintero E, Ginès P, Arroyo V, Rimóla A, Bory F, Planas R, Viver J, Cabrera J, Rodés J (1985) Paracentesis versus diuretics in the treatment of cirrhotics with tense ascites. Lancet 1:611–612
Ramond MJ, Polynard T, Rueff B, Mathurin P, Theodore C, Chaput JC, Benhamou JP (1992) A randomized trial of prednisolone in patients with severe alcoholic hepatitis. N Engl J Med 326:507–512
Reynolds TB (1987) Therapeutic paracentesis. Gastroenterology 93:386–388
Reynolds TB (1990) Corticosteroid therapy of alcoholic hepatitis: How many studies will it take? Hepatology 12:619–621
Rocco VK, Ware AJ (1986) Cirrhotic ascites. Ann Intern Med 105:573–585
Rossi V, Calés P, Burtin P, Charneau J, Person B, Pujol P, Valentin S, D’Aubigny N, Joubaud F, Boyer J (1991) Prevention of recurrent variceal bleeding in alcoholic cirrhotic patients: prospective controlled trial of propranolol and sclerotherapy. J Hepatol 12:283–289
Salmi HA, Sarna S (1982) Effect of Silymarin on chemical, functional and morphological alterations of the liver. A double-blind controlled study. Scand J Gastroenterol 17:517–521
Sauerbruch T, Wotzka R, Kopeke W, Härlin M, Heldwein W, Bayerdörffer E, Sander R, Ansari H, Starz I, Paumgartner G (1988) Prophylactic sclerotherapy before the first episode of variceal hemorrhage in patients with cirrhosis. N Engl J Med 319:8–15
Schafer DF, Jones EA (1982) Hepatic encephalopathy and the y-aminobutyric-acid neurotransmitter system. Lancet 1:18–20
Schrier RW, Arroyo V, Bernardi M, Epstein M, Henriksen JH, Rodés J (1988) Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis. Hepatology 8:1151–1157
Schwedes M, Althoff PH, Klempa L (1979) Effects of somatostatin on bile induced acute haemorrhagic pancreatitis in the dog. Horm Metab Res 11:647
Sherlock S (1990) Alcoholic hepatitis. Alcohol Alcohol 25:189–196
Shocket ID (1992) Paracentesis or peritoneovenous shunting for ascites? ACP J Club 116 [Suppl 1]:10
Simon D, Galambos JT (1988) A randomized controlled study of peripheral parenteral nutrition in moderate and severe alcoholic hepatitis. J Hepatol 7:200–207
Sørensen TIA, Orholm M, Bentsen K, Høybye G, Eghoje K, Christoffersen P (1984) Prospective evaluation of alcohol abuse and alcoholic liver injury in men as predictors of development of cirrhosis. Lancet 2:241–244
Stanley MM, Ochi S, Lee KK, Allen MJ, Baum RA, Gadacz TR, Camara DS, Caruana JA, Schiff ER, Livingstone AS, Samanta AK, Najem AZ, Glick ME, Juler GL, Adham N, Baker JD, Cain GD, Jordan PH, Wolf DC, Fulenwider JT, James KE, VA Cooperative Study on Treatment of Alcoholic Cirrhosis with Ascites (1989) Peritoneovenous shunting as compared with medical treatment in patients with alcoholic cirrhosis and massive ascites. N Engl J Med 321: 1632–1638
Starzl TE, Van Thiel D, Tzakis AG, Iwatsuki S, Todo S, Marsh JW, Koneru B, Staschak S, Stieber A, Gordon RD (1988) Orthotopic liver transplantation for alcoholic cirrhosis. JAMA 260:2542–2544
Stiegmann GV, Goff JS, Michaletz-Onody PA, Korula J, Lieberman D, Saeed ZA, Reveille RM, Sun JH, Lowenstein SR (1992) Endoscopic sclerotherapy as compared with endoscopic ligation for bleeding esophageal varices. N Engl J Med 326:1527–1532
Szauter KM, Mullen KD (1989) Management of hepatic encephalopathy. Pract Gastroenterol 13:40–48, 68
Terblanche J, Burroughs AK, Hobbs KEF (1989a) Controversies in the management of bleeding esophageal varices. N Engl J Med 320:1393–1398
Terblanche J, Burroughs AK, Hobbs KEF (1989b) Controversies in the management of bleeding esophageal varices. N Engl J Med 320:1469–1475
Tito L, Ginés P, Arroyo V, Planas R, Panés J, Rimmola A, Llach J, Humbert P, Badalamenti S, Jiménez W, Rodés J (1990) Total paracentesis associated with intravenous albumin management of patients with cirrhosis and ascites. Gastroenterology 98:146–151
Trinchet JC, Beaugrand M, Callard P, Hartmann DJ, Gotheil C, Nusgens BV, Lapiere CM, Ferrier JP (1989) Treatment of alcoholic hepatitis with colchicine. Gastroenterol Clin Biol 13:551–555
Trinchet JC, Balkau B, Poupon RE, Heintzmann F, Callard P, Gotheil C, Grange JD, Vetter D, Pauwels A, Labadie H, Chazouilleres O, Mavier P, Desmorat H, Zarski JP, Barbare JC, Chambre JF, Pariente EA, Roulot D, Beaugrand M (1992) Treatment of severe alcoholic hepatitis by infusion of insulin and glucagon: a multicenter sequential trial. Hepatology 15:76–81
Uppal R, Lateef SK, Korsten MA, Paronetto F, Lieber CS (1991) Chronic alcoholic gastritis. Role of alcohol and Helicobacter pylori. Arch Intern Med 151:760–764
VA Cooperative Variceal Sclerotherapy Group (1991) Prophylactic sclerotherapy for esophageal varices in men with alcoholic liver disease. N Engl J Med 324: 1779–1784
Valenzuela JE, Weiner K, Saad C (1986) Cholinergic stimulation of human pancreatic secretion. Dig Dis Sci 31:615–619
Van Thiel DH, Carr B, Iwatsuki S, Tzakis A, Fung JJ, Starzl TE (1991) Liver transplantation for alcoholic liver disease, viral hepatitis, and hepatic neoplasms. Transplant Proc 23:1917–1921
World MJ, Ryle PR, Aps EJ, Shaw GK, Thomson AD (1987) Palmitoyl-catechin for alcoholic liver disease: results of a three-month clinical trial. Alcohol Alcohol 22:331–340
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1995 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Worner, T.M., Manu, P. (1995). Pharmacology of Gastrointestinal Comorbidity in Alcoholics. In: Kranzler, H.R. (eds) The Pharmacology of Alcohol Abuse. Handbook of Experimental Pharmacology, vol 114. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-78435-4_16
Download citation
DOI: https://doi.org/10.1007/978-3-642-78435-4_16
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-78437-8
Online ISBN: 978-3-642-78435-4
eBook Packages: Springer Book Archive